Perceived Risk of Trying Lysergic Acid Diethylamide in the United States from 2015 to 2019: Are Americans Assessing Lysergic Acid Diethylamide's Risk Profile More Favorably? [0.03%]
2015至2019年美国人对尝试脱氧麻疹酸二乙基胺的风险感知：美国人是否越来越有利地评估脱氧麻疹酸二乙基胺的风险特征？
为了更符合中文表达习惯，可以进一步简化为：
2015年至2019年美国民众对尝试LSD风险的感知变化：美国人对其风险评价更加积极了吗？
Brian S Barnett,Akhil Anand,Elizabeth N Dewey et al.
Brian S Barnett et al.
Background: Though lysergic acid diethylamide (LSD) use is rising in the United States amid expanding research into the therapeutic potential of psychedelics, little scholarly work exists on whether perceived risk of tryi...
Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence [0.03%]
迷幻药物使用中的保护性行为策略：证据的简要回顾
Cianna J Piercey,Bethany Gray,Angelina Sung et al.
Cianna J Piercey et al.
Background: Approximately 8.5 million Americans over the age of 12 endorsed past year psychedelic use in 2022, with 1.4 million individuals initiating use during this time. Although emerging evidence indicates there may b...
Low-Dose LSD Alters Early and Late Event-Related Potentials to Emotional Faces [0.03%]
低剂量的LSD会改变对情绪化人脸的早、晚期事件相关电位反应
Connor Haggarty,Hanna Molla,James Glazer et al.
Connor Haggarty et al.
Introduction: Despite widespread popular interest in the use of low doses of Lysergic acid diethylamide (LSD) to improve mood, little is known about how these doses affect emotional processing in the brain. In this study,...
The Role of Music in Psychedelic-Assisted Therapy: A Comparative Analysis of Neuroscientific Research, Indigenous Entheogenic Ritual, and Contemporary Care Models [0.03%]
音乐在迷幻辅助治疗中的作用：神经科学研究、本土恩特基因仪式和当代护理模式的比较分析
Amanda Argot Efthimiou,Amanda M Cardinale,Agnieszka Kepa
Amanda Argot Efthimiou
Music is deeply rooted in the human experience as well as a fundamental part of psychedelic-assisted therapies (PAT) and entheogenic ceremonies. Although a large body of research exists highlighting the importance of music from rehabilitati...
Preferences and Attitudes Toward Music in Nonclinical Uses of Psychedelics [0.03%]
非临床用途中对迷幻药物使用的态度和音乐偏好
Sara G Gloeckler,Alexandre Lehmann,Sara de la Salle et al.
Sara G Gloeckler et al.
Background: The resurgent interest in psychedelic-assisted therapy for conditions like depression, end-of-life anxiety, and post-traumatic stress disorder is generating highly promising results. Within this therapeutic co...
Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy [0.03%]
团体用裸盖菇素辅助治疗的临床试验中触碰行为使用指南的演进
Anthony Back,Susanna Myers,John Guy et al.
Anthony Back et al.
For a new clinical trial testing a group retreat-based format of psilocybin-assisted therapy, our research team created an initial set of practice guidelines that aimed to describe facilitator use of touch in a way that is ethical, supporti...
Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion [0.03%]
迷幻药物的过去、现在与未来：一次关于迷幻治疗的圆桌讨论
Peter S Hendricks,Charles D Nichols,Kathryn A Cunningham et al.
Peter S Hendricks et al.
Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents [0.03%]
麦角酸二乙基酰胺改变啮齿动物大脑刺激的影响
Lucas Dwiel,Angela Henricks,Elise Bragg et al.
Lucas Dwiel et al.
Background: Psychedelic drugs have resurged in neuroscience and psychiatry with promising success in psychedelic-assisted therapy for the treatment of anxiety, depression, and addiction. At the cellular level, psychedelic...
Incilius alvarius Cell-Based Synthesis of 5-Methoxy-N,N-Dimethyltryptamine [0.03%]
Incilius alvarius 细胞基 5-甲氧基-N,N-二甲基色胺合成
Leonard Lerer,Eric Reynolds,Jeet Varia et al.
Leonard Lerer et al.
There is growing interest in the therapeutic potential of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for psychiatric disorders. Although 5-MeO-DMT can be chemically synthesized, the parotoid gland secretions of Incilius alvarius (also kno...